Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety

The combination of immunosuppressants and chemotherapy has reshaped the treatment landscape for esophageal cancer (EC). This study aimed to evaluate the effectiveness and safety of a neoadjuvant immunochemotherapy (nICT) regimen in patients with resectable EC. A total of 99 eligible patients were i...

Full description

Bibliographic Details

Published in:	Biomolecules & Biomedicine
Main Authors:	Xiaomin Wang, Bingxu Li, Zhiyong Zheng, Weijie Wang
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-04-01
Subjects:	Immunotherapy chemotherapy neoadjuvant therapy esophageal cancer EC neoadjuvant immunochemotherapy
Online Access:	http://www.bjbms.org/ojs/index.php/bjbms/article/view/11806